Literature DB >> 22843258

Focal atrophy on MRI and neuropathologic classification of dementia with Lewy bodies.

Kejal Kantarci1, Tanis J Ferman, Bradley F Boeve, Stephen D Weigand, Scott Przybelski, Prashanthi Vemuri, Melissa E Murray, Melissa M Murray, Matthew L Senjem, Glenn E Smith, David S Knopman, Ronald C Petersen, Clifford R Jack, Joseph E Parisi, Dennis W Dickson.   

Abstract

OBJECTIVE: To determine the association between the focal atrophy measures on antemortem MRI and postmortem neuropathologic classification of dementia with Lewy bodies (DLB) using the Third Report of the DLB Consortium criteria.
METHODS: We retrospectively identified 56 subjects who underwent antemortem MRI and had Lewy body (LB) pathology at autopsy. Subjects were pathologically classified as high (n = 25), intermediate (n = 22), and low likelihood DLB (n = 9) according to the Third Report of the DLB Consortium criteria. We included 2 additional pathologic comparison groups without LBs: one with low likelihood Alzheimer disease (AD) (control; n = 27) and one with high likelihood AD (n = 33). The associations between MRI-based volumetric measurements and the pathologic classification of DLB were tested with analysis of covariance by adjusting for age, sex, and MRI-to-death interval.
RESULTS: Antemortem hippocampal and amygdalar volumes increased from low to intermediate to high likelihood DLB (p < 0.001, trend test). Smaller hippocampal and amygdalar volumes were associated with higher Braak neurofibrillary tangle stage (p < 0.001). Antemortem dorsal mesopontine gray matter (GM) atrophy was found in those with high likelihood DLB compared with normal control subjects (p = 0.004) and those with AD (p = 0.01). Dorsal mesopontine GM volume decreased from low to intermediate to high likelihood DLB (p = 0.01, trend test).
CONCLUSION: Antemortem hippocampal and amygdalar volumes increase and dorsal mesopontine GM volumes decrease in patients with low to high likelihood DLB according to the Third Report of the DLB Consortium criteria. Patients with high likelihood DLB typically have normal hippocampal volumes but have atrophy in the dorsal mesopontine GM nuclei.

Entities:  

Mesh:

Year:  2012        PMID: 22843258      PMCID: PMC3413765          DOI: 10.1212/WNL.0b013e31826357a5

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  37 in total

1.  Antemortem differential diagnosis of dementia pathology using structural MRI: Differential-STAND.

Authors:  Prashanthi Vemuri; Gyorgy Simon; Kejal Kantarci; Jennifer L Whitwell; Matthew L Senjem; Scott A Przybelski; Jeffrey L Gunter; Keith A Josephs; David S Knopman; Bradley F Boeve; Tanis J Ferman; Dennis W Dickson; Joseph E Parisi; Ronald C Petersen; Clifford R Jack
Journal:  Neuroimage       Date:  2010-12-31       Impact factor: 6.556

2.  Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study.

Authors:  Melissa E Murray; Neill R Graff-Radford; Owen A Ross; Ronald C Petersen; Ranjan Duara; Dennis W Dickson
Journal:  Lancet Neurol       Date:  2011-07-27       Impact factor: 44.182

3.  Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study.

Authors:  K M Gosche; J A Mortimer; C D Smith; W R Markesbery; D A Snowdon
Journal:  Neurology       Date:  2002-05-28       Impact factor: 9.910

4.  Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease.

Authors:  K L Newell; B T Hyman; J H Growdon; E T Hedley-Whyte
Journal:  J Neuropathol Exp Neurol       Date:  1999-11       Impact factor: 3.685

5.  Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry.

Authors:  E J Burton; G Karas; S M Paling; R Barber; E D Williams; C G Ballard; I G McKeith; P Scheltens; F Barkhof; J T O'Brien
Journal:  Neuroimage       Date:  2002-10       Impact factor: 6.556

6.  Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia.

Authors:  Hiroshige Fujishiro; Eizo Iseki; Shinji Higashi; Koji Kasanuki; Norio Murayama; Takashi Togo; Omi Katsuse; Hirotake Uchikado; Naoya Aoki; Kenji Kosaka; Heii Arai; Kiyoshi Sato
Journal:  Neurosci Lett       Date:  2010-09-17       Impact factor: 3.046

7.  Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies.

Authors:  T J Ferman; B F Boeve; G E Smith; S-C Lin; M H Silber; O Pedraza; Z Wszolek; N R Graff-Radford; R Uitti; J Van Gerpen; W Pao; D Knopman; V S Pankratz; K Kantarci; B Boot; J E Parisi; B N Dugger; H Fujishiro; R C Petersen; D W Dickson
Journal:  Neurology       Date:  2011-08-17       Impact factor: 9.910

8.  Dementia with Lewy bodies and Alzheimer disease: neurodegenerative patterns characterized by DTI.

Authors:  K Kantarci; R Avula; M L Senjem; A R Samikoglu; B Zhang; S D Weigand; S A Przybelski; H A Edmonson; P Vemuri; D S Knopman; T J Ferman; B F Boeve; R C Petersen; C R Jack
Journal:  Neurology       Date:  2010-06-01       Impact factor: 9.910

9.  MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study.

Authors:  J L Whitwell; K A Josephs; M E Murray; K Kantarci; S A Przybelski; S D Weigand; P Vemuri; M L Senjem; J E Parisi; D S Knopman; B F Boeve; R C Petersen; D W Dickson; C R Jack
Journal:  Neurology       Date:  2008-09-02       Impact factor: 9.910

10.  Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis.

Authors:  E J Burton; R Barber; E B Mukaetova-Ladinska; J Robson; R H Perry; E Jaros; R N Kalaria; J T O'Brien
Journal:  Brain       Date:  2008-11-20       Impact factor: 13.501

View more
  40 in total

Review 1.  The relationship between atrophy and hypometabolism: is it regionally dependent in dementias?

Authors:  María C Rodriguez-Oroz; Belen Gago; Pedro Clavero; Manuel Delgado-Alvarado; David Garcia-Garcia; Haritz Jimenez-Urbieta
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

2.  Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease.

Authors:  Val J Lowe; Emily S Lundt; Sabrina M Albertson; Scott A Przybelski; Matthew L Senjem; Joseph E Parisi; Kejal Kantarci; Bradley Boeve; David T Jones; David Knopman; Clifford R Jack; Dennis W Dickson; Ronald C Petersen; Melissa E Murray
Journal:  Alzheimers Dement       Date:  2019-06-04       Impact factor: 21.566

3.  Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies.

Authors:  Zuzana Nedelska; Tanis J Ferman; Bradley F Boeve; Scott A Przybelski; Timothy G Lesnick; Melissa E Murray; Jeffrey L Gunter; Matthew L Senjem; Prashanti Vemuri; Glenn E Smith; Yonas E Geda; Jonathan Graff-Radford; David S Knopman; Ronald C Petersen; Joseph E Parisi; Dennis W Dickson; Clifford R Jack; Kejal Kantarci
Journal:  Neurobiol Aging       Date:  2014-07-15       Impact factor: 4.673

Review 4.  Molecular imaging of Alzheimer disease pathology.

Authors:  K Kantarci
Journal:  AJNR Am J Neuroradiol       Date:  2014-02-06       Impact factor: 3.825

5.  Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies.

Authors:  Tanis J Ferman; Glenn E Smith; Kejal Kantarci; Bradley F Boeve; V Shane Pankratz; Dennis W Dickson; Neill R Graff-Radford; Zbigniew Wszolek; Jay Van Gerpen; Ryan Uitti; Otto Pedraza; Melissa E Murray; Jeremiah Aakre; Joseph Parisi; David S Knopman; Ronald C Petersen
Journal:  Neurology       Date:  2013-11-08       Impact factor: 9.910

6.  Brain injury biomarkers are not dependent on β-amyloid in normal elderly.

Authors:  David S Knopman; Clifford R Jack; Heather J Wiste; Stephen D Weigand; Prashanthi Vemuri; Val J Lowe; Kejal Kantarci; Jeffrey L Gunter; Matthew L Senjem; Michelle M Mielke; Rosebud O Roberts; Bradley F Boeve; Ronald C Petersen
Journal:  Ann Neurol       Date:  2013-02-19       Impact factor: 10.422

7.  In vivo hippocampal subfield shape related to TDP-43, amyloid beta, and tau pathologies.

Authors:  Veronika Hanko; Alexandra C Apple; Kathryn I Alpert; Kristen N Warren; Julie A Schneider; Konstantinos Arfanakis; David A Bennett; Lei Wang
Journal:  Neurobiol Aging       Date:  2018-10-25       Impact factor: 4.673

8.  Regional proton magnetic resonance spectroscopy patterns in dementia with Lewy bodies.

Authors:  Jonathan Graff-Radford; Bradley F Boeve; Melissa E Murray; Tanis J Ferman; Nirubol Tosakulwong; Timothy G Lesnick; Mandie Maroney-Smith; Matthew L Senjem; Jeffrey Gunter; Glenn E Smith; David S Knopman; Clifford R Jack; Dennis W Dickson; Ronald C Petersen; Kejal Kantarci
Journal:  Neurobiol Aging       Date:  2014-01-08       Impact factor: 4.673

9.  Amyloid-β deposition and regional grey matter atrophy rates in dementia with Lewy bodies.

Authors:  Lidia Sarro; Matthew L Senjem; Emily S Lundt; Scott A Przybelski; Timothy G Lesnick; Jonathan Graff-Radford; Bradley F Boeve; Val J Lowe; Tanis J Ferman; David S Knopman; Giancarlo Comi; Massimo Filippi; Ronald C Petersen; Clifford R Jack; Kejal Kantarci
Journal:  Brain       Date:  2016-07-24       Impact factor: 13.501

10.  Harnessing advances in structural MRI to enhance research on Parkinson's disease.

Authors:  David A Ziegler; Jean C Augustinack
Journal:  Imaging Med       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.